Journal
NATURE CHEMICAL BIOLOGY
Volume 2, Issue 5, Pages 249-253Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nchembio782
Keywords
-
Categories
Funding
- NINDS NIH HHS [NS050636] Funding Source: Medline
Ask authors/readers for more resources
Oxidative stress, inflammation and alpha-synuclein overexpression(1) confer risk for development of alpha-synucleinopathies neurodegenerative diseases that include Parkinson disease and Lewy body dementia(2). Dopaminergic neurons undergo degeneration in these diseases and are particularly susceptible to oxidative stress because dopamine metabolism itself creates reactive oxygen species(3). Intraneuronal deposition of alpha-synuclein as amyloid fibrils or Lewy bodies is the hallmark of these diseases(2). Herein, we demonstrate that concentrations of oxidative cholesterol metabolites derived from reactive oxygen species are elevated in the cortices of individuals with Lewy body dementia relative to those of age-matched controls, and we show that these metabolites accelerate alpha-synuclein aggregation in vitro. The increase in the production of these cytotoxic cholesterol metabolites is also observed in a dopaminergic cell line that overexpresses alpha-synuclein(4). By extension, these data lead to the hypothesis that oxidative stress produces cholesterol aldehydes that enable alpha-synuclein aggregation, leading to a pathologic cycle.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available